<DOC>
	<DOCNO>NCT01194050</DOCNO>
	<brief_summary>This observational study investigate tolerability efficacy Tarceva ( erlotinib ) daily clinical practice routine condition patient locally advance metastatic non small cell lung cancer . Data collect approximately 12 month .</brief_summary>
	<brief_title>An Observational Study Tarceva ( Erlotinib ) Routine Practice For First Line Maintenance Therapy Patients With Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Adult patient locally advance metastatic nonsmall cell lung cancer ( stage IIIb IV ) stable disease 4 cycle standard platinumbased firstline chemotherapy Not willing able sign write informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>